Bio-Rad Laboratories (BIO.B) to Release Earnings on Tuesday

Bio-Rad Laboratories (NYSE:BIO.B) is scheduled to release its earnings data after the market closes on Tuesday, May 7th.

Bio-Rad Laboratories (NYSE:BIO.B) last released its quarterly earnings data on Thursday, February 15th. The company reported $3.10 EPS for the quarter. The firm had revenue of $681.18 million for the quarter. Bio-Rad Laboratories had a negative net margin of 23.86% and a positive return on equity of 3.90%.

Bio-Rad Laboratories Stock Performance

Shares of BIO.B remained flat at $279.91 on Tuesday. The company had a trading volume of 2 shares, compared to its average volume of 87. The company has a debt-to-equity ratio of 0.14, a current ratio of 5.83 and a quick ratio of 4.34. Bio-Rad Laboratories has a 1-year low of $271.00 and a 1-year high of $467.95. The company’s fifty day moving average is $326.03 and its 200-day moving average is $316.86.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.